EPTIFIBATIDE INJECTION 2 MG
EPTIFIBATIDE : 2 MG · DIN 02410125 · OMEGA LABORATORIES LIMITED
Health Canada status: CANCELLED PRE MARKET
What is EPTIFIBATIDE INJECTION?
EPTIFIBATIDE INJECTION 2 MG contains EPTIFIBATIDE : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02410125, held by OMEGA LABORATORIES LIMITED, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled pre market, status dated 29-Jul-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is EPTIFIBATIDE INJECTION used for?
EPTIFIBATIDE INJECTION is indicated for the treatment of patients presenting with symptoms of unstable angina (UA)/non-ST-segment elevation myocardial infarction (NSTEMI), including those patients who may subsequently undergo percutaneous coronary intervention (PCI) as well as those who will be managed medically. EPTIFIBATIDE INJECTION is indicated for the treatment of patients undergoing PCI including those undergoing intracoronary stenting.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02410125 |
|---|---|
| Brand name | EPTIFIBATIDE INJECTION |
| Generic / active ingredient | EPTIFIBATIDE : 2 MG |
| Manufacturer | OMEGA LABORATORIES LIMITED |
| Strength | 2 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | B01AC16 EPTIFIBATIDE |
| AHFS class | 20:12.18 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 29-Jul-2026 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code B01AC16 EPTIFIBATIDE. 2 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| EPTIFIBATIDE INJECTION | 0.75 MG | Solution | JUNO PHARMACEUTICALS CORP. | MARKETED | DIN 02540819 |
| EPTIFIBATIDE INJECTION | 2 MG | SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED | DIN 02540827 |
| EPTIFIBATIDE INJECTION | 0.75 MG | SOLUTION | ACCORD HEALTHCARE INC | CANCELLED PRE MARKET | DIN 02454483 |
| EPTIFIBATIDE INJECTION | 0.75 MG | SOLUTION | OMEGA LABORATORIES LIMITED | CANCELLED PRE MARKET | DIN 02410109 |
| EPTIFIBATIDE INJECTION | 0.75 MG | SOLUTION | STRIDES PHARMA CANADA INC | APPROVED | DIN 02422840 |
| EPTIFIBATIDE INJECTION | 0.75 MG | SOLUTION | TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02405083 |
| EPTIFIBATIDE INJECTION | 0.75 MG | SOLUTION | FRESENIUS KABI CANADA LTD | CANCELLED PRE MARKET | DIN 02460378 |
| EPTIFIBATIDE INJECTION | 2 MG | SOLUTION | STRIDES PHARMA CANADA INC | APPROVED | DIN 02422859 |
| EPTIFIBATIDE INJECTION | 2 MG | SOLUTION | TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02367858 |
| EPTIFIBATIDE INJECTION | 2 MG | SOLUTION | ACCORD HEALTHCARE INC | CANCELLED PRE MARKET | DIN 02454491 |
Who else supplies EPTIFIBATIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. EPTIFIBATIDE appears in 7 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.